Principal Investigator: Dr. Aileen Chang​
Disease: Dengue Fever
Research Description: Dengue viruses (DenV) are among the leading causes of pediatric morbidity and mortality globally, with 96 million symptomatic cases annually worldwide and no targeted treatments. Once infected by DenV, individuals who are symptomatic often experience high fever, muscle and joint pain, and rash. However, some individuals can develop more severe symptoms leading to dengue shock syndrome. Low and lower-middle income countries suffer from DenV infections disproportionately, due to lack of healthcare infrastructure and capacity to manage dengue cases.
Repurposing a Flu Treatment for Severe Dengue Patients in Colombia
Latest News
We are proud to announce the latest publications from our lab, highlighting our contributions to infectious disease research and clinical advancements!
We are pleased to introduce the Latin American Trials and Research Network (LATIN) which is coordinated by the Chang Lab at George Washington University (GWU) and now part of the ISARIC Consortium.
We are thrilled to announce that the Latin American Trials and Research Network (LATIN) is now part of the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC).